Vanguard Group Inc Aziyo Biologics, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,180,505 shares of AZYO stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,180,505
Previous 988,605 19.41%
Holding current value
$1.71 Million
Previous $1.43 Million 19.4%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
N/A
191,900 Added 19.41%
1,180,505 $1.71 Million
Q1 2025

May 09, 2025
BUY
N/A
55,870 Added 5.99%
988,605 $1.43 Million
Q4 2024

Feb 11, 2025
BUY
N/A
433,690 Added 86.9%
932,735 $1.35 Million
Q3 2024

Nov 13, 2024
BUY
N/A
13,539 Added 2.79%
499,045 $723,000
Q2 2024

Aug 13, 2024
BUY
N/A
69,796 Added 16.79%
485,506 $703,000
Q1 2024

May 10, 2024
BUY
N/A
120,526 Added 40.83%
415,710 $602,000
Q4 2023

Feb 14, 2024
BUY
$1.14 - $1.45 $47,663 - $60,624
41,810 Added 16.5%
295,184 $428,000
Q3 2023

Nov 14, 2023
SELL
$1.13 - $2.52 $1,675 - $3,737
-1,483 Reduced 0.58%
253,374 $362,000
Q2 2023

Aug 14, 2023
BUY
$1.41 - $2.79 $8,974 - $17,758
6,365 Added 2.56%
254,857 $601,000
Q1 2023

May 15, 2023
BUY
$1.19 - $4.96 $41,683 - $173,738
35,028 Added 16.41%
248,492 $375,000
Q4 2022

Feb 10, 2023
BUY
$3.48 - $8.94 $479,892 - $1.23 Million
137,900 Added 182.49%
213,464 $907,000
Q2 2022

Aug 12, 2022
BUY
$5.75 - $7.41 $114,965 - $148,155
19,994 Added 35.98%
75,564 $534,000
Q3 2021

Nov 12, 2021
BUY
$6.75 - $9.52 $2,085 - $2,941
309 Added 0.56%
55,570 $386,000
Q2 2021

Aug 13, 2021
BUY
$9.51 - $13.97 $525,532 - $771,996
55,261 New
55,261 $531,000

Others Institutions Holding AZYO

# of Institutions
29
Shares Held
17.3M
Call Options Held
0
Put Options Held
0
View Full List

About AZIYO BIOLOGICS, INC.

AZYO Quotes by TradingView
  • Ticker AZYO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,308,720
  • Market Cap $13.5M
  • Description
  • Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...
More about AZYO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email